SRNE

Sorrento Therapeutics, Inc.

Delisted

SRNE was delisted on the 22nd of February, 2023.

15 hedge funds and large institutions have $27.5M invested in Sorrento Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

Holders
15
Holders Change
+14
Holders Change %
+1,400%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
14
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$11.9M 1,470,161 +1,470,161 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$5.27M 650,000 +650,000 New
AC
3
Aisling Capital
New York
$5M 620,700 +620,700 New
SM
4
Sabby Management
Florida
$1.8M 222,026 +222,026 New
BIT
5
BlackRock Institutional Trust
California
$1.04M 127,929 +127,929 New
LMF
6
LMR Master Fund
Cayman Islands
$915K 113,000 +113,000 New
Bank of America
7
Bank of America
North Carolina
$463K 57,138 +57,138 New
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$437K 53,916 +53,916 New
SC
9
Sophrosyne Capital
New York
$316K 38,900 +38,900 New
MAA
10
Matrix Asset Advisors
New York
$187K 23,128 -1,500 -6%
EEG
11
E.E. Geduld
$122K 15,000 +15,000 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$89K 11,040 +11,040 New
U
13
UBS
Switzerland
$7K 922 +922 New
Deutsche Bank
14
Deutsche Bank
Germany
$4K 557 +557 New
Wells Fargo
15
Wells Fargo
California
$0 1 +1 New